Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTriad Regulatory News (TRD)

Share Price Information for Triad (TRD)

Share Price is delayed by 15 minutes
Get Live Data
285.00    0.00 (0.00%)
Bid:
280.00
Ask:
290.00
Spread: 10.00 (3.571%)
Market Cap: £49.67m
TRD Live PriceLast checked at - London Stock Exchange

Intraday Triad Share Chart

Director/PDMR Shareholding

20 Jan 2026 14:30

RNS Number : 6305P
Triad Group Plc
20 January 2026
 

Legal Entity Identifier (LEI) No. 213800MDNBFVEQEN1G84

Triad Group Plc

("Triad" or "the Company")

Director Dealings

The Company announces that it has been informed that, on 19 January 2026, Tim Eckes (Client Services Director) has in order to effect a "Bed and ISA" transaction, sold 3,251 ordinary shares of £0.01 each ("Ordinary Shares") at a price of 240.00 pence per Ordinary Share and then repurchased into his Individual Savings Account (ISA), the same number of 3,251 Ordinary Shares at an average price of 241.04 pence per Ordinary Share.

Following the completion of these transactions his ultimate beneficial ownership is unchanged and remains at 147,180 Ordinary Shares in total, representing approximately 0.84% of the Company's total voting rights.

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail on the transactions.

1.

Details of PDMR / person closely associated with them

a)

Name

Tim Eckes

2.

Reason for the notification

a)

Position / status

Director

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Triad Group Plc

b)

LEI

213800MDNBFVEQEN1G84

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument;(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of £0.01 each

 

ISIN: GB0009035741

b)

Nature of the transaction

On market sale of Ordinary Shares and immediate repurchase by way of Bed and ISA arrangement

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£2.4000 (sale)

£2.4100 (purchase)

£2.4500 (purchase)

3,251

3,221

30

d)

Aggregated information

-Aggregated sale

-Aggregated purchase

 

3,251 - average price of £2.4000

3,251 - average price of £2.4104

e)

Date of the transaction

19 January 2026

f)

Place of the transaction

LONDON STOCK EXCHANGE XLON

 

For further information, please contact:

Triad Group Plc

James McDonald

Finance Director and Company Secretary

01908 278 450

 

Zeus Capital Limited

Darshan Patel

Tel: 020 7614 5900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUROURNSUAUAR
Date   Source Headline
2nd Mar 20261:00 pmRNSDirectorate change
5th Feb 202611:00 amRNSDirector/PDMR Shareholding
27th Jan 20262:00 pmRNSDirector Dealing
20th Jan 20262:30 pmRNSDirector/PDMR Shareholding
23rd Dec 202512:00 pmRNSTotal Voting Rights
23rd Dec 202512:00 pmRNSTotal Voting Rights
25th Nov 20257:00 amRNSHalf-year Financial Report
26th Sep 20253:00 pmRNSDirector dealings
15th Sep 202512:00 pmRNSBlock listing Review
20th Aug 20252:30 pmRNSNotification of Major Holdings
18th Aug 20252:00 pmRNSDirector/PDMR Shareholding
30th Jul 202510:30 amRNSResult of AGM
7th Jul 20253:45 pmRNSNotice of AGM and Dividend declaration
2nd Jul 202510:30 amRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSFinal Results
1st Apr 202511:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
19th Mar 20254:00 pmRNSDirector/PDMR Shareholding
14th Mar 20252:00 pmRNSBlock listing Review
7th Nov 20247:00 amRNSHalf-year Report
5th Nov 20244:30 pmRNSCommittee changes
30th Sep 20242:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20242:00 pmRNSDirector/PDMR Shareholding
20th Sep 20242:00 pmRNSDirectorate Change
16th Sep 20242:30 pmRNSBlock listing Interim Review
5th Sep 202412:00 pmRNSHolding(s) in Company
23rd Aug 20242:00 pmRNSResult of AGM
22nd Aug 202411:00 amRNSTrading Statement
9th Aug 20243:00 pmRNSHolding(s) in Company
31st Jul 20243:00 pmRNSNotice of AGM
31st Jul 20242:00 pmRNSHolding(s) in Company
31st Jul 20242:00 pmRNSDirector/PDMR Shareholding
29th Jul 20242:00 pmRNSDirector/PDMR Shareholding
25th Jul 20242:00 pmRNSTotal Voting Rights
25th Jul 20242:00 pmRNSDividend and AGM declaration
15th Jul 202410:00 amRNSHolding(s) in Company
11th Jul 202411:45 amRNSDirector/PDMR Shareholding
10th Jul 20241:57 pmRNSHolding(s) in Company
10th Jul 20241:55 pmRNSHolding(s) in Company
10th Jul 20241:50 pmRNSHolding(s) in Company
3rd Jul 202412:30 pmRNSDirector/PDMR Shareholding
3rd Jul 202412:30 pmRNSDirector/PDMR Shareholding
3rd Jul 202412:30 pmRNSHolding(s) in Company
3rd Jul 202412:30 pmRNSDirector/PDMR Shareholding
1st Jul 20243:00 pmRNSDirectorate Change
26th Jun 20247:00 amRNSAnnual Financial Report
14th Jun 202412:00 pmRNSHolding(s) in Company
3rd Jun 202410:00 amRNSTotal Voting Rights
1st May 20245:00 pmRNSTotal Voting Rights
1st May 20245:00 pmRNSHolding(s) in Company
14th Mar 20243:00 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.